<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00680797</url>
  </required_header>
  <id_info>
    <org_study_id>ARCD-034-04F</org_study_id>
    <nct_id>NCT00680797</nct_id>
  </id_info>
  <brief_title>Metabolic Effects of Androgenicity in Aging Men and Women</brief_title>
  <official_title>Metabolic Effects of Androgenicity in Aging Men and Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this research study is to study the effect of testosterone or estrogen on blood
      sugar control and fat metabolism. Changes in hormone levels with age may affect risk factors
      for heart disease such as diabetes. Diabetes is a glandular condition associated with lack of
      the hormone insulin or an insensitivity to it resulting in problems with blood sugar control
      and fat metabolism. The effect of commonly used hormonal supplements such as testosterone by
      older adults on insulin and body composition is not well understood. In this study, the role
      of testosterone and estrogen on your ability to control blood sugar and your body composition
      will be assessed.

      The investigators plan to study 60 subjects. All of these subjects will be healthy older men
      between the ages of 60-85 years old who are not on testosterone therapy. Subjects that are
      screened who have any clinically significant abnormalities detected on their screening
      physical exam or laboratory testing (e.g. Prostate Specific Antigen &gt; 4), who have a history
      of prostate cancer, polycythemia, or who cannot take testosterone will not be included.

      If a subject is eligible to participate after initial screening, that subject will take
      medications to adjust their hormone levels and have tests performed that measure insulin
      sensitivity and adiposity before and after these hormone medications. The outcomes that will
      be measured are: 1) insulin sensitivity, 2) hormone levels (total and free testosterone
      levels, sex hormone-binding globulin levels) and 3) body composition and abdominal adiposity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2005</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 31, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin Sensitivity</measure>
    <time_frame>6 weeks</time_frame>
    <description>As measured by change in insulin levels pre- and post-hormone changes</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Aging</condition>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>+T +E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>+Testosterone, +Estrogen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>+T -E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>+Testosterone, -Estrogen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>-T +E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>-Testosterone, +Estrogen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>-T -E</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>-Testosterone, -Estrogen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Testosterone</intervention_name>
    <description>Testosterone gel</description>
    <arm_group_label>+T +E</arm_group_label>
    <arm_group_label>+T -E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Estrogen</intervention_name>
    <description>Estrogen patch</description>
    <arm_group_label>+T +E</arm_group_label>
    <arm_group_label>-T +E</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  males age 60-85 years

          -  non-diabetic fasting glucose and 2-hour oral glucose tolerance test (OGTT)

          -  overall good general medical health and signed informed consent

          -  willing to travel to West Los Angeles VA and University of California, Los Angeles in
             Los Angeles, California

        Exclusion Criteria:

          -  any clinically significant abnormalities detected on screening physical exam or
             laboratory testing (e.g. prostate specific antigen &gt; 4)

          -  or other symptom or history of a significant underlying medical or psychiatric illness

          -  BMI &lt; 20 or &gt; 40

          -  subjects already on testosterone therapy or medications that might influence glucose
             regulation or hormone levels

          -  subjects with a history of deep venous thromboses, pulmonary embolism, breast cancer,
             prostate cancer, polycythemia or other contraindications to estrogen or testosterone
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cathy C Lee, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Greater Los Angeles Healthcare System, West Los Angeles, CA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Greater Los Angeles Healthcare System, West Los Angeles, CA</name>
      <address>
        <city>West Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2008</study_first_submitted>
  <study_first_submitted_qc>May 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2008</study_first_posted>
  <results_first_submitted>July 24, 2014</results_first_submitted>
  <results_first_submitted_qc>February 19, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 21, 2016</results_first_posted>
  <last_update_submitted>May 22, 2017</last_update_submitted>
  <last_update_submitted_qc>May 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aging</keyword>
  <keyword>Hormones</keyword>
  <keyword>Insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
    <mesh_term>Estrogens</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment methods included flyers and advertisement in local newspapers. Healthy Veteran and community participants who responded to to advertisement were screened by telephone for exclusion criteria. If no exclusion criteria were reported, participants were scheduled for a screening history and physical.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>+T +E</title>
          <description>+Testosterone, +Estrogen
Testosterone: Testosterone gel
Estrogen: Estrogen patch</description>
        </group>
        <group group_id="P2">
          <title>+T -E</title>
          <description>+Testosterone, -Estrogen
Testosterone: Testosterone gel</description>
        </group>
        <group group_id="P3">
          <title>-T +E</title>
          <description>-Testosterone, +Estrogen
Estrogen: Estrogen patch</description>
        </group>
        <group group_id="P4">
          <title>-T -E</title>
          <description>-Testosterone, -Estrogen</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>+T +E</title>
          <description>+Testosterone, +Estrogen
Testosterone: Testosterone gel
Estrogen: Estrogen patch</description>
        </group>
        <group group_id="B2">
          <title>+T -E</title>
          <description>+Testosterone, -Estrogen
Testosterone: Testosterone gel</description>
        </group>
        <group group_id="B3">
          <title>-T +E</title>
          <description>-Testosterone, +Estrogen
Estrogen: Estrogen patch</description>
        </group>
        <group group_id="B4">
          <title>-T -E</title>
          <description>-Testosterone, -Estrogen</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="8"/>
            <count group_id="B4" value="8"/>
            <count group_id="B5" value="33"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67" spread="8"/>
                    <measurement group_id="B2" value="66" spread="5"/>
                    <measurement group_id="B3" value="69" spread="6"/>
                    <measurement group_id="B4" value="63" spread="3"/>
                    <measurement group_id="B5" value="66" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body-Mass-Index</title>
          <units>kilogram/meter squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.1" spread="4.9"/>
                    <measurement group_id="B2" value="28.6" spread="4.3"/>
                    <measurement group_id="B3" value="28.2" spread="4.1"/>
                    <measurement group_id="B4" value="29.0" spread="2.9"/>
                    <measurement group_id="B5" value="28.2" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total testosterone</title>
          <units>nanogram/deciliter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="419.6" spread="146.5"/>
                    <measurement group_id="B2" value="418.9" spread="207.7"/>
                    <measurement group_id="B3" value="480.0" spread="231.7"/>
                    <measurement group_id="B4" value="558.3" spread="362.9"/>
                    <measurement group_id="B5" value="467.7" spread="242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Insulin Sensitivity</title>
        <description>As measured by change in insulin levels pre- and post-hormone changes</description>
        <time_frame>6 weeks</time_frame>
        <population>Two participants had missing values post-intervention therefore number of participants analyzed total 31.</population>
        <group_list>
          <group group_id="O1">
            <title>+T +E</title>
            <description>+Testosterone, +Estrogen
Testosterone: Testosterone gel
Estrogen: Estrogen patch</description>
          </group>
          <group group_id="O2">
            <title>+T -E</title>
            <description>+Testosterone, -Estrogen
Testosterone: Testosterone gel</description>
          </group>
          <group group_id="O3">
            <title>-T +E</title>
            <description>-Testosterone, +Estrogen
Estrogen: Estrogen patch</description>
          </group>
          <group group_id="O4">
            <title>-T -E</title>
            <description>-Testosterone, -Estrogen</description>
          </group>
        </group_list>
        <measure>
          <title>Insulin Sensitivity</title>
          <description>As measured by change in insulin levels pre- and post-hormone changes</description>
          <population>Two participants had missing values post-intervention therefore number of participants analyzed total 31.</population>
          <units>micro International Units/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="10.8"/>
                    <measurement group_id="O2" value="2.62" spread="5.47"/>
                    <measurement group_id="O3" value="-0.50" spread="2.54"/>
                    <measurement group_id="O4" value="1.83" spread="4.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>The major outcome variable being presented is changes in insulin levels. Changes in insulin levels were analyzed using an ANCOVA model that adjusted for baseline insulin and age.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.023</p_value>
            <p_value_desc>Comparison of pre- to post-intervention insulin levels between the groups receiving E only versus the group receiving no hormone replacement.</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The major outcome variable being presented is changes in insulin levels. Changes in insulin levels were analyzed using an ANCOVA model that adjusted for baseline insulin and age.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.042</p_value>
            <p_value_desc>Comparison in the change in insulin levels between the groups receiving E with or without T.</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>+T +E</title>
          <description>+Testosterone, +Estrogen
Testosterone: Testosterone gel
Estrogen: Estrogen patch</description>
        </group>
        <group group_id="E2">
          <title>+T -E</title>
          <description>+Testosterone, -Estrogen
Testosterone: Testosterone gel</description>
        </group>
        <group group_id="E3">
          <title>-T +E</title>
          <description>-Testosterone, +Estrogen
Estrogen: Estrogen patch</description>
        </group>
        <group group_id="E4">
          <title>-T -E</title>
          <description>-Testosterone, -Estrogen</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small sample size may limit generalizability of these results. Follow-up studies are being conducted to further evaluate these results.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Cathy Lee</name_or_title>
      <organization>VA Greater Los Angeles</organization>
      <phone>310-478-3711 ext 42627</phone>
      <email>cathy.lee2@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

